Physician profile
Caleb James Smith
NPI 1497434534
$286.13
in general payments reported to CMS, 2019-2025
8 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $36.20 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $59.70 | 2024-2025 | Xeomin, Ampyra, Inbrija |
| Ossur Americas, INC. | $53.28 | 2025 | |
| Stryker Corporation | $51.87 | 2025 | Adherus Autospray Dural Sealant, Universal Neuro 3 |
| Vertex Pharmaceuticals Incorporated | $31.01 | 2025 | |
| Radius Health, INC. | $26.08 | 2025 | Tymlos |
| Averitas Pharma INC. | $25.49 | 2025 | Qutenza |
| Heron Therapeutics, INC. | $23.75 | 2025 | Zynrelef |
| Lemaitre Vascular, INC. | $14.95 | 2025 | Anastoclip Gc 8cm (Medium) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.